Trials / Completed
CompletedNCT05850715
Cross-cultural Adaptation of the Greek Version of Disability Assessment for Dementia
Translation, Cross-cultural Adaptation, Reliability and Validity of the Greek Version of the Disability Assessment for Dementia Scale (DAD-Gr)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- University of Thessaly · Academic / Other
- Sex
- All
- Age
- 60 Years – 95 Years
- Healthy volunteers
- Accepted
Summary
The main purpose of this study is primarily the translation and cross-cultural adaptation into Greek and then the investigation of validity and reliability in the Greek target population.
Detailed description
Two investigators will do the translation into Greek, then a third person independent of the first two will translate the scale backward, i.e. into English. Then, the three investigators will meet with another independent investigator who is familiar with the field of Greek translations of foreign language rating scales. Thus, the final translation and Greek version of the scale will be created. Then, the process of finding the participants will begin and the first assessment with the scale will be carried out initially. After two days will take place reassessment for the reliability of the measurement tool. In order to find the validity of the scale in the Greek population, in the first assessment will be used also Katz index for Basic Activities of Daily Living and the Lawton scale for Instrumental Activities of Daily Living.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Disability Assessment for Dementia (DAD) | The scale consists of 40 items and assesses patients' independence in basic and instrumental activities. The scale is completed by the patient's caregiver with the assistance of the assessor-therapist. |
Timeline
- Start date
- 2023-05-12
- Primary completion
- 2023-06-05
- Completion
- 2023-08-31
- First posted
- 2023-05-09
- Last updated
- 2023-12-06
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT05850715. Inclusion in this directory is not an endorsement.